Medicine and Dentistry
Neoplasm
100%
Bladder Cancer
88%
Neoadjuvant Chemotherapy
70%
Bladder Tumor
49%
Circulating Tumor DNA
49%
Muscle Invasive Bladder Cancer
48%
Mutational Analysis
44%
T Cell Development
44%
Cystoscopy
44%
Aminolevulinic Acid Hexyl Ester
44%
DNA Determination
44%
Transitional Cell Carcinoma
44%
Transurethral Resection
39%
Cystectomy
29%
Urinary System
24%
Treatment Response
18%
Bladder
14%
Bladder Biopsy
14%
Non Muscle Invasive Bladder Cancer
14%
Tumor Microenvironment
13%
Immunocompetent Cell
13%
Recurrent Disease
9%
Urine Sampling
9%
Disease
9%
Bacilli
9%
Outcome Assessment
9%
Cytotoxic T-Cell
9%
Cell Composition
8%
Rank Sum Test
8%
Biochemistry, Genetics and Molecular Biology
Supernatant
44%
Bacilli
44%
T Cell
44%
Genomics
44%
Urine Sampling
33%
Tumor Volume
22%
Dynamics
22%
Immune Response
22%
ARID1A
22%
CD8
22%
Angiogenesis
22%
Proteomics
22%
Urine Level
22%
Exome Sequencing
22%
Fibroblast Growth Factor Receptor 3
22%
DNA Mutation
11%
Germline
11%
Circulating Tumor DNA
11%
Germ Cell
11%
Next Generation Sequencing
11%
Immunocompetent Cell
11%
Loss of Heterozygosity
11%
Cell Cycle
11%
Genome Instability
11%
Whole Genome Sequencing
11%
RNA Sequence
11%
Tamsulosin
11%
Keyphrases
DNA mutational Analysis
44%
Urine DNA
44%
Neoadjuvant Chemotherapy Response
44%
Chemotherapy Outcomes
44%
Biological Analysis
44%
Advanced Urothelial Carcinoma
44%
Breast Cancer Survivors
44%
Urine Supernatant
33%
Kinesio Taping
14%
Volume Reduction
14%
DNA Dynamics
11%
Immune Composition
11%
Immune Cell Exhaustion
11%
Shallow Whole Genome Sequencing (sWGS)
11%
Integrative Clustering
11%
Genomically Stable
11%
Cell Cycle Genes
11%
Pathological Downstaging
7%
Combined Measures
5%
Plasma Detection
5%
Somatic mutation Analysis
5%
NGS Panel
5%
